![](https://sourceonhealth.wpenginepowered.com/wp-content/uploads/2019/04/SLIHCQ-title-1.png)
HF 4 (see companion bill SF 1518) – Minnesota
Status: Inactive / DeadYear Introduced: 2019
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&y=2019&ssn=0&f=HF0004
Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found